
The Impact of the EMA Change in Definition of “Dose” on the BCS Dose-Solubility Ratio: A Review of the Biowaiver Monographs
Keywords: فراهم زیستی; biopharmaceutics classification system (BCS); bioavailability; bioequivalence; regulatory science;